Electrochemical Interferences in BGM | DSR
Technology & Innovation

Electrochemical Interferences in BGM

Electrochemical interference in blood glucose monitoring (BGM) happens when physical properties of the blood or non-glucose substances change the electrical current a test strip produces, so the meter shows a reading that is too high or too low. The biggest physical interference is the Hematocrit Effect: low hematocrit tends to push readings up and high hematocrit tends to pull them down. Some meters correct for it, for example with AC Impedance measurements, but correction methods and results vary from meter to meter.

Chemical interferences come from redox-active substances (e.g., Acetaminophen, Vitamin C, Uric Acid) that react at the electrode. Low-potential mediators, such as ruthenium complexes, reduce but don't eliminate this. GDH-PQQ strips also react with maltose and other sugars; FDA linked this Maltose interference to 13 deaths reported from 1997 to 2009, most in patients on icodextrin dialysis solution. Many strips now use GDH-FAD or GDH-NAD, though Roche's Aviva Plus strips use a mutant GDH-PQQ. Glucose Oxidase (GOx) strips are also sensitive to the oxygen level of the sample.

Diabetic Supply Rescue Editorial Team
5 min read
Last updated: October 09, 2026
Last reviewed: October 09, 2026
Advanced
12 glossary terms
12 citations

Electrochemical Interferences in Blood Glucose Monitoring

Introduction

Electrochemical interference is anything that changes the current a test strip produces for a reason other than glucose. A blood glucose meter (BGM) converts that current into a number, so extra electrons from another source show up as a falsely high reading [5]. The causes fall into two groups. Some are physical properties of the sample, such as the share of red blood cells; others are substances in the blood that react at the strip [4].

Physical Interferences

The largest physical interference is the Hematocrit Effect. Hematocrit is the percentage of blood volume taken up by red blood cells. Studies of many meters have found that a lower-than-normal hematocrit (below roughly 30 to 35%) tends to give readings above the laboratory value, while a higher-than-normal hematocrit (above 45%) tends to give readings below it [3]. Nobody has settled on a single cause. Proposed explanations include changes in blood viscosity, red cells keeping plasma away from the strip's reaction surface, and slower diffusion [3]. Hematocrit also moves more than people expect: smoking, exercise, pregnancy, time in the mountains and hemodialysis can all shift it [3].

Meters deal with this in different ways. With Roche's Accu-Chek Aviva Plus strips, the meter first sends small alternating-current (AC) signals at four frequencies through the sample, then applies a direct-current (DC) voltage to measure glucose, and combines the two into a result compensated for hematocrit and temperature [6]. That AC approach is one design among several, not something every meter does. Here's what surprised us: in a 2011 laboratory study of 13 meters, the four self-test meters that showed less than 10% bias between the highest and lowest hematocrit levels used either dynamic electrochemistry (BGStar) or conventional "static" electrochemistry (Contour, Glucocard G+ and OneTouch Verio) [3]. The Accu-Chek Aviva tested in that study showed a 23% bias [3]. Those were the meters of 2011, so the study shows how much hematocrit handling varied, not how today's meters rank.

Chemical Interferences

Some substances in blood are redox-active, meaning they can give up electrons at the strip's electrode the way the glucose reaction does. Acetaminophen, vitamin C (ascorbic acid) and uric acid are common examples [5]. When they are oxidized at the electrode, they add current the meter counts as glucose and push the reading up [5]. The size and even the direction of the effect depend on the strip. A 2009 review listed acetaminophen as lowering readings on the glucose oxidase systems it covered, listed ascorbic acid as variable, and said uric acid matters only at very high levels [4]. FDA's 2020 guidance for over-the-counter meters asks manufacturers to test known or potential interferents, maltose and acetaminophen among them, and to evaluate varying hematocrit levels [2].

Manufacturers' main chemical defense is the mediator, the molecule that carries electrons from the enzyme to the electrode. An interfering molecule is one that is electroactive at the sensor's operating potential [5], so a strip that runs at a lower voltage gives fewer substances the chance to react [7]. Hexaammineruthenium(III), a ruthenium complex, lets strips run at a lower operating potential than potassium ferricyanide, the most common mediator in commercial strips; as the authors of one study put it, a lower operating potential generally leads to fewer interferences [7]. That means fewer, not none. Abbott's FreeStyle strips, as their developers described them in 2010, use an osmium mediator with a low formal potential, but the stated reason was to stop current shuttling between the strip's two closely spaced electrodes rather than to screen out interferents [8].

Oxygen is a separate problem for strips that use Glucose Oxidase (GOx). Oxygen competes with the mediator for electrons from the enzyme, and the electrode reads only the mediator [4]. Strips are generally calibrated for the oxygen level of capillary blood. A high-oxygen sample, such as arterial blood or blood from someone on supplemental oxygen, can read falsely low; a low-oxygen sample, such as venous blood, can read falsely high [4]. The same review notes that GOx meters are generally not approved for venous blood, and that glucose dehydrogenase (GDH) meters were more accurate than GOx meters in a high-altitude study [4]. GDH chemistry doesn't depend on dissolved oxygen [5].

Historical Context

GDH-PQQ strips use glucose dehydrogenase with the cofactor pyrroloquinoline quinone. The enzyme also reacts with maltose, xylose and galactose, so these sugars can falsely raise the result and hide a dangerously low blood sugar [1]. From 1997 to 2009, FDA received 13 reports of deaths in which maltose or another non-glucose sugar interfered with GDH-PQQ strips. The deaths occurred in healthcare facilities, and 10 of the 13 patients were receiving Extraneal (icodextrin) peritoneal dialysis solution [1], which the body breaks down mainly into maltose [5]. FDA laid out these risks in an August 2009 public health notification [1].

As of October 2026, many strips use other GDH forms. Accu-Chek Guide strips use FAD-dependent GDH (GDH-FAD) [9][11], and FreeStyle Precision Neo strips use NAD-dependent GDH (GDH-NAD) [10]. The move away from PQQ wasn't complete, though. Roche still lists Accu-Chek Aviva Plus test strips as of October 2026 [11], and those strips use a modified ("mutant") GDH-PQQ [6]. Their FDA clearance summary still names galactose above 15 mg/dL as a cause of overestimated results [6]. A 2017 case report adds a caution about maltose: intravenous immunoglobulin (IVIG) containing maltose spilled onto a patient's hand and produced a falsely high reading on an Accu-Chek Performa meter, which also uses mutant GDH-PQQ [12]. Which meter suits someone on peritoneal dialysis or maltose-containing drugs is a decision for that person's care team.

References

  1. FDA Public Health Notification: Potentially Fatal Errors with GDH-PQQ Glucose Monitoring Technology (August 13, 2009; archived FDA page)Source
  2. Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use: Guidance for IndustrySource
  3. Dynamic electrochemistry corrects for hematocrit interference on blood glucose determinations with patient self-measurement devices (Musholt PB, et al. J Diabetes Sci Technol. 2011;5(5):1167-1175)Source
  4. Factors Affecting Blood Glucose Monitoring: Sources of Errors in Measurement (Ginsberg BH. J Diabetes Sci Technol. 2009;3(4):903-913)Source
  5. Glucose Biosensors: An Overview of Use in Clinical Practice (Yoo EH, Lee SY. Sensors (Basel). 2010;10(5):4558-4576)Source
  6. FDA 510(k) Decision Summary K101299: ACCU-CHEK Aviva Plus Blood Glucose Monitoring SystemSource
  7. Mediator Preference of Two Different FAD-Dependent Glucose Dehydrogenases Employed in Disposable Enzyme Glucose Sensors (Loew N, et al. Sensors (Basel). 2017;17(11):2636)Source
  8. Electrochemistry in diabetes management (Heller A, Feldman B. Acc Chem Res. 2010;43(7):963-973)Source
  9. FDA 510(k) Decision Summary K160944: ACCU-CHEK Guide Blood Glucose Monitoring SystemSource
  10. FDA 510(k) Decision Summary K171941: FreeStyle Precision Neo Blood Glucose Test StripsSource
  11. Test Strips: General FAQs (Accu-Chek US, Roche)Source
  12. Erroneously elevated glucose values due to maltose interference in mutant glucose dehydrogenase pyrroloquinolinequinone (mutant GDH-PQQ) based glucometer (Chakraborty PP, et al. BMJ Case Rep. 2017)Source

Was this article helpful?

Explore More Topics

Continue your research with related categories